SCHEMBL10028664

SCHEMBL10028664

Cc1nc(Cl)nc(Cc2nc(C)nc(Cl)n2)n1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13500216 0.82 LMNA (0.34) ALDH1A1ALOX15TSHRLMNA
SCHEMBL15249283 0.80 ALDH1A1 (0.32) ALDH1A1ALOX15TSHR
SCHEMBL134064 0.80
SCHEMBL17123447 0.80 ALDH1A1 (0.57) ALDH1A1ALOX15TSHRLMNA
SCHEMBL17486265 0.80 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL802854 0.76
SCHEMBL94294 0.76
SCHEMBL2678562 0.67 PDE4A (0.54) ALDH1A1LMNA
SCHEMBL15248718 0.67 HTT (0.43) ALDH1A1TSHRLMNA
SCHEMBL11254 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124720-B2 Triazine-based monomeric compound, di-triazine compound, and degradable polymer NATIONAL CHI NAN UNIVERSITY (TW) 2012-02-28 US disclosed
US-20090312520-A1 Triazine-Based Monomeric Compound, Di-Triazine Compound, and Degradable Polymer NATIONAL CHI NAN UNIVERSITY (TW) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312520-A1 Triazine-Based Monomeric Compound, Di-Triazine Compound, and Degradable Polymer CCNB2, CCND2, CCNB1 ALDH1A1 1449/4885ALOX15 1217/4885TSHR 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.